22.2 Pharmacotherapy: Antidepressants Flashcards
Describe the onset of effects of antidepressants (2)
- relief of neuro-vegetative/physical symptoms: 1-3 wk
- relief of emotional/cognitive symptoms: 2-6 wk
Describe tapering of antidepressants (2)
- tapering of most antidepressants is usually required to avoid withdrawal reactions;
- speed of taper is based on the medication’s half-life and the patient’s individual sensitivity
Name an antidepressant that does not require a taper
fluoxetine does not require a taper due to its long half-life
Name antidepressants that require a slower taper than sertraline or citalopram
paroxetine and venlafaxine require a slower taper than sertraline or citalopram
Describe the treatment of bipolar depression with antidepressants (2)
- patients with bipolar disorder should only be treated with an antidepressant if combined with a mood stabilizer or antipsychotic
- monotherapy with antidepressants is not advisable as the depression can switch to mania
Name examples of SSRIs (6)
- fluoxetine (Prozac®)
- fluvoxamine (Luvox®)
- paroxetine (Paxil®)
- sertraline (Zoloft®)
- citalopram (Celexa®)
- escitalopram (Cipralex®)
Explain use of fluoxetine (Prozac®) (5)
Useful for
- typical and atypical depression
- seasonal depression
- anxiety disorders
- OCD
- eating disorders
Compare effectiveness of SSRIs (1)
All SSRIs have similar effectiveness but consider side effect profiles and half-lives
Name the SSRIs that have the fewest drug-interactions and are sleep-wake neutral (2)
Citalopram, and escitalopram
Name the safest SSRI in pregnancy and breastfeeding
Sertraline is the safest
Name the most activating SSRI (recommend taking in the AM)
Fluoxetine (Prozac®)
Name the most used SSRI in children
Fluoxetine is the most used in children as it has most evidence
Fluoxetine does not require a taper why?
due to long half-life
Describe: Fluvoxamine (Luvox®) (2)
- Fluvoxamine is sedating (should be taken in PM)
- can be involved in many drug-drug interactions
Name examples of SNRIs (3)
- venlafaxine (Effexor®)
- Desvenlafaxine (Pristiq®)
- duloxetine (Cymbalta®)
SNRIs are useful for what? (3)
Useful for depression, anxiety disorders, neuropathic pain
Name example norepinephrine and dopamine reuptake inhibitors NDRI (1)
bupropion (Wellbutrin®)
Bupropion (Wellbutrin®) is useful for what? And not recommended for what? (2)
- Useful for depression, seasonal depression
- not recommended for anxiety disorder treatment because of stimulating effects
Name pros and cons of Wellbutrin (2)
- Causes less sexual dysfunction (may reverse effects of SSRIs/SNRIs), weight gain, and sedation
- Increased risk of seizures at higher doses
Name contraindications of wellbutrin (5)
Contraindicated with
- history of seizure
- stroke
- brain tumour
- brain injury
- closed head injury
Name examples tricyclic antidepressants (3º Amines) (2)
- amitriptyline (Elavil®)
- imipramine (Tofranil®)
Name TCA (3º Amines) useful for OCD (1)
Clomipramine (Anafranil)
Describe: TCA (3º Amines) (5)
- Useful for OCD (clomipramine)
- melancholic depression
- requires ECG monitoring
- check blood levels if using higher dosage
- highly lethal in overdose
Name examples TCA (2º Amines) (2)
- nortriptyline (Aventyl®)
- desipramine (Norpramin®)
Describe TCA (2º Amines) (4)
- Preferred to tertiary amines because of lower propensity for anticholinergic adverse effects
- requires ECG monitoring
- check blood levels if using higher dosage
- highly lethal in overdose
Name examples of monoamine oxidase inhibitors MAOI (2)
- phenelzine (Nardil®)
- tranylcypromine (Parnate®)
Describe monoamine oxidase inhibitors MAOI (2)
- Useful for moderate/severe depression that does not respond to other antidepressants, atypical depression;
- requires strict adherence to MAOI diet
Name example reversible inhibition of MAO-A (RIMA) (1)
moclobemide (Manerix®)
Describe use: Reversible inhibition of MAO-A (RIMA) (1)
Useful for depression that does not respond to other antidepressants
Describe example: Noradrenergic and specific serotonin antagonists (NASSA) (3)
Useful in depression with prominent features
- insomnia
- agitation
- cachexia
Describe treatment Approach for Depression (5)
- optimization: increase dosage to maximum tolerated or highest therapeutic dosage
- augmentation: the addition of a medication that is not considered an antidepressant to an antidepressant regimen (i.e. thyroid hormone, lithium, atypical antipsychotics [aripiprazole, quetiapine, olanzapine, risperidone])
- combination: the addition of another antidepressant to an existing treatment regimen (i.e. the addition of bupropion or mirtazapine to an SSRI or SNRI)
- switch: change of the primary antidepressant (within or outside a class)
- note: it is important to fully treat depression symptoms (i.e. to remission) to decrease relapse rates

Name antidepressants that are worst in terms of 5HT2C/5HT2A in brain activation (insomnia, anxiety)
- Fluoxetine
- Paroxetine
Describe effect/side effect: Post-Synaptic Serotonin Receptor Stimulated
- 5HT1A centrally
- 5HT2A in spinal cord
- 5HT2C/5HT2A in brain
- 5HT3A in gut

Describe mode of action: SSRI (1)
Block serotonin reuptake only
Describe side effects: SSRI (14)
- Fewer than TCA, therefore increased compliance
- CNS:
- restlessness
- tremor
- insomnia
- headache
- drowsiness
- GI:
- N/V
- diarrhea
- abdominal cramps
- Weight gain
- Sexual dysfunction:
- erectile dysfunction
- anorgasmia
- CVS:
- increased HR
- Serotonin syndrome SIADH
- EPS
Describe Risk in overdose: SSRI (1)
Relatively safe in OD
Describe drug interactions: SSRI (3)
- MAOI
- SNRI
- Some SSRIs (fluoxetine, fluvoxamine, paroxetine) strongly inhibit cytochrome P450 enzymes, therefore will affect levels of drugs metabolized by P450 system
Describe mode of action: SNRI (1)
Block norepinephrine and serotonin reuptake
Describe side effects: SNRI (7)
- Low dose side effects similar to SSRIs (serotonergic)
- Higher dose side effects:
- tremors, tachycardia
- sweating
- insomnia
- orthostatic hypotension
- increase in BP (noradrenergic)
- SIADH
Describe risk of overdose: SNRI (2)
Tachycardia and N/V seen in acute overdose
Describe drug interactions: SNRI (3)
- MAOI
- SSRI
- Low inhibition of cytochrome P450 compounds
Describe mode of action: TCA (1)
Block norepinephrine reuptake (clomipramine also blocks serotonin reuptake)
Describe side effects: TCA (11)
- Anticholinergic effects:
- Dry mouth
- urinary retention
- constipation
- blurred vision
- confusional states
- Noradrenergic effects:
- tremors
- tachycardia
- sweating
- α-1 adrenergic effects:
- orthostatic hypotension
- falls
- QRS prolongation
Describe risk of overdose: TCA (4)
- Toxic in OD
- 3 times therapeutic dose may be lethal
- Presentation: anticholinergic effects, CNS stimulation, then depression and seizures
- ECG: prolonged QRS and QTc (reflect severity)
Describe tx of overdose: TCA (6)
- activated charcoal
- cathartics
- supportive treatment
- IV diazepam for seizure
- physostigmine salicylate for coma
- Do not give ipecac, as can cause rapid neurologic deterioration and seizures
Describe drug interactions: TCA (3)
- MAOI
- SSRI
- EtOH
Name example: MAOI (1)
Phenelzine
Describe mode of action: MAOI (1)
Irreversible inhibition of monoamine oxidase A and B increases duration that NE and 5HT are in the synaptic cleft by preventing their degradation
Name side effets: MAOI (10)
- Antihistamine effects: sedation, weight gain
- CVS:
- orthostatic hypotension
- hypertensive crises with tyramine rich foods (i.e. wine, cheese):
- headache
- flushes
- reflex tachycardia
- postural hypotension
- sedation
- insomnia
- weight gain
- Minimal anticholinergic and antihistamine effects
Describe risk in overdose: MAOI (2)
- Toxic in OD
- but wider margin of safety than TCA
Describe drug interactions: MAOI (2)
- Hypertensive crises with noradrenergic medications (i.e. TCA, decongestants, amphetamines)
- Serotonin syndrome with serotonergic drugs (i.e. SSRI, SNRI, tryptophan, dextromethorphan)
Name example: NDRI (1)
Buproprion
Describe mode of action: NDRI (1)
Block norepinephrine and dopamine reuptake
Name side effects: NDRI (12)
- CNS:
- dizziness
- headache
- tremor
- insomnia
- CVS:
- dysrhythmia
- HTN
- GI:
- dry mouth
- N/V
- constipation
- decreased appetite
- Other:
- agitation
- anxiety
Describe risk in overdose: NDRI (2)
Tremors and seizures seen in overdose
Describe drug interaction: NDRI (2)
- MAOI
- Drugs that reduce seizure threshold: antipsychotics, systemic steroids, quinolone antibiotics, antimalarial drugs
Name example: RIMA (1)
Moclobemide
Describe mode of action: RIMA (2)
- Reversible inhibitor of monoamine oxidase
- A leads to increased duration NE and 5HT are in the synaptic cleft by preventing their degradation
Name side effects: RIMA (13)
- CNS:
- dizziness
- headache
- tremor
- insomnia
- CVS:
- dysrhythmia
- hypotension
- GI:
- dry mouth
- N/V
- diarrhea
- abdominal pain
- dyspepsia
- GU:
- delayed ejaculation
- Other: diaphoresis
Describe risk in overdose: RIMA (1)
Risk of fatal overdose when combined with SSRIs, SNRIs or clomipramine
Describe drug interaction: RIMA (3)
- MAOI
- paroxetine
- Opioids
Name example: NASSA (1)
Mirtazapine
Describe mode of action: NASSA (1)
Enhance central noradrenergic and serotonergic activity by inhibiting presynaptic a-2 adrenergic receptors
Name side effects: NASSA (7)
- CNS:
- sedation
- dizziness
- Endocrine:
- increase in cholesterol
- triglycerides
- weight gain
- GI:
- constipation
- ALT
Describe risk in overdose: NASSA (1)
Relatively safe in OD
Describe drug interactions: NASSA (2)
MAOI, RIMA
Describe: Serotonin Syndrome (4)
- thought to be due to over-stimulation of the serotonergic system
- can result from medication combinations such as SSRI+SNRI, SSRI or SNRI +MAOI, SSRI+tryptophan, MAOI+meperidine, MAOI+tryptophan
- rare but potentially life-threatening adverse reaction to SSRIs and SNRIs
- important to distinguish from NMS
Describe symptoms: Serotonin Syndrome (9)
- nausea
- diarrhea
- palpitations
- chills
- diaphoresis
- restlessness
- confusion
- and lethargy
- but can progress to myoclonus, hyperthermia, rigor, and hypertonicity
Describe tx: Serotonin Syndrome (2)
- discontinue medication
- and administer emergency medical care as needed
Name sx: Discontinuation Syndrome (6)
FINISH
- Flu-like symptoms
- Insomnia
- Nausea
- Imbalance
- Sensory disturbances
- Hyperarousal (anxiety/agitation)
Describe: Discontinuation Syndrome (3)
- caused by the abrupt cessation of some antidepressants
- symptoms usually begin within 1-3 d
- consider avoiding drugs with a short half-life
Name most common drugs that cause Discontinuation Syndrome (3)
- paroxetine, fluvoxamine, and venlafaxine (drugs with shortest half-lives)
Describe tx: Discontinuation Syndrome (2)
- symptoms may last between 1-3 wk
- but can be relieved within 24 h by restarting antidepressant at the same dosage the patient was taking and initiating a slower taper over several weeks
Name: Symptoms of Antidepressant Discontinuation (6)
FINISH
- Flu-like symptoms
- Insomnia
- Nausea
- Imbalance
- Sensory disturbances
- Hyperarousal (anxiety/agitation)